Biotech Investors & VC Firms in China

238 firms in this list, with a median first check of $1M. 38 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
CARELA Holding GmbH	Hamburg	DE	—	—	+ Add to CRM
Biomark Capital 4 people	Greenwich	US	Series A–Late Stage	$5M – $10M	+ Add to CRM
Stonebridge Ventures 3 people	Seoul	KR	Series A–Series C	—	+ Add to CRM
Morningside Group 1 person	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
Vincera Capital 2 people	Taipei	TW	Seed–Late Stage	$500K – $10M	+ Add to CRM
Hong Kong Science and Technology Parks – incubation programs 4 people	Hong Kong	HK	Pre-Seed–Growth	—	+ Add to CRM
10x Genomics 4 people	Pleasanton	US	—	—	+ Add to CRM
Nan Fung Life Sciences 1 person	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
CBC Group 2 people	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
ShangPharma Innovation 2 people	South San Francisco	US	Seed–Series A	—	+ Add to CRM
CDIB Capital	Hong Kong	HK	Series A–Series C	—	+ Add to CRM
Hermes-Epitek 1 person	Hsinchu	TW	Seed	—	+ Add to CRM
HSBC Innovation Ventures 1 person	London	GB	Seed–Growth	—	+ Add to CRM
Lake Bleu Capital	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
Hong Kong X Technology Fund	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
Cdh Venture Management Company Limited	Hong Kong	HK	Series A–Series C	—	+ Add to CRM
China Development Industrial Bank (CDIB)	Taipei	TW	Series A–Series B	—	+ Add to CRM